Skip to content

Public FDA record

Z-2760-2016: The system provides the ability to transmit patient data files for storage, viewing and analysis at distr

Recall record Z-2760-2016 for Invivo Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-2760-2016
Company in FDA record
Invivo Corporation
FDA record creation date
Sep 8, 2016
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Display of SpO2 and Non-Invasive Blood Pressure (NIBP) Measurements May Freeze

Source facts

Action
Phillips Medical Systems sent out a letter to their customers, dated October 19, 2015. The letter notified customers and distributors of the voluntary recall of the Xper Flex Cardio Patient Monitoring System, and identified the product issue as "Display o fSpO2 and NIBP measurements may freeze". Phillips assured customers that the recalled device can be used if each monitored patient is closely observed and not left unattended. These directions are directed within the instructions of the manual for regular use. Continued use is advised until Phillips contacts the individual customer to correct the issue with a software update. Some hardware is more dated, so software updates will require special handling. If customers have any additional questions, they are encouraged to contact their local Phillips representative. For further questions, please call (877) 468- 4861 option 1 then option 2.
Initiated
2015-10-19
Root cause
Unknown/Undetermined by firm
Terminated
2019-10-04
Distribution
Nationwide Distribution to the states of :AL, AR, AZ, CA, CO, CT, DE, FL, GA, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TX, TN, UT, VA, WA, WI, WV, Alaska, Hawaii, & Washington, DC. Worldwide Distribution to the countries of : Algeria, Argentina, Australia, Austria, Bangladesh, Belgium, Bulgaria, Canada, Cayman Islands, Chile, Columbia, Croatia, Democratic Republic of Congo, Denmark, Ecuador, Egypt, Estonia, France, Germany, Greece, Hungary, Iceland, India, Indonesia, Islamic Republic of Iran, Ireland, Israel, Italy, Jordan, Kazakhstan, Republic of Korea, Lebanon, Libya, Malaysia, Mauritius, Mexico, Morocco, Myanmar, Nepal, Netherlands, New Zealand, Norway, Oman, Pakistan, State of Palestine, Panama, Papua New Guinea, Philippines, Poland, Puerto Rico, Qatar, Reunion, Romania, Russian Federation, Saudi Arabia, Singapore, South Africa, Spain, Sri Lanka, Sweden, Switzerland, Taiwan, Taiwan Province, Thailand, Tunisia, Turkey, United Arab Emirates, United Kingdom, United Republic of Tanzania, Uzbekistan, & Vietnam.
Recall number
Z-2760-2016
Recall status
Terminated
CDRH record ID
145526
FDA record created
2016-09-08
Recall event number
73196

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗